Anti Biofilm Effect of Biogenic Silver Nanoparticles Coated Medical Devices Against Biofilm of Clinical Isolate of Staphylococcus Aureus
Keywords:
biogenic silver nanoparticles, biofilm, catheter
Abstract
Biofilm represents the most prevalent type of virulent factor of most of the pathogenic microorganism and involved in crucial development of clinical infection and exhibit resistance to antimicrobial agents. Now the biofilm is considered as major target for the pharmacological development of drugs. A biofilm serves to promote bacteria persistence by resisting antibiotic treatment and host immune responses. Antibiotics are rendered ineffective when biofilms form due to their relative impermeability, the variable physiological status of microorganisms, subpopulations of persistent strains, and variations of phenotypes present. Metal nanotechnology chemistry has the potential to prevent the formation of these life-threatening biofilms on life supporting devices. In the present study, anti biofilm effect of silver nanoparticles coated catheter against clinical isolate of Staphylococcus Aureus was studied. Silver nanoparticles synthesized by leaf extract broth of Azadirhacta indica were coated on the catheter chara-cterized by scanning electron microscopy which reveals complete dispersion of the nanoparticles on the fibre surface of the catheter and the size, shape of the particles shows uniform spherical particles with the size of 50-60 nm. Distinct effect of biofilm inhibition was recorded in the nanoparticles coated catheter and maximum inhibition was observed during 72 hour of incubation. Biochemical composition of biofilm matrix mainly total carbohydrates and total protein was highly reduced. The present study would suggests the development of anti microbial coated medical devices against pathogenic microorganism.
Downloads
- LaTeX Kaleidoscope* (Beta by AI)
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
How to Cite
References
Allison Adonizio, Kok-Fai Kong, Kalai Mathee (2008) Inhibition of Quorum Sensing-Controlled Virulence Factor Production in Pseudomonas aeruginosa by South Florida Plant Extracts. 52(1), 198-203.
R Darouiche (2004) Unknown Title. 350, 1422-1429.
M Davey, O' Toole, G (2000) Unknown Title. 350, 847-867.
R Donlan, J Costerton (2002) Unknown Title. 15, 167-193.
Michel. Dubois, K Gilles, J Hamilton, P Rebers, Fred. Smith (1956) Colorimetric Method for Determination of Sugars and Related Substances. 28(3), 350-356.
Luanne Hall-Stoodley, J Costerton, Paul Stoodley (2004) Bacterial biofilms: from the Natural environment to infectious diseases. 2(2), 95-108.
Karthick Raja, Namasivayam, Allen Roy, E (2013) Anti biofilm effect of edicinal plant extracts against clinical isolate of biofilm of Escherichia coli. 5(2), 486-489.
S Karthick Raja Namasivayam, M Preethi, Arvind Bharani, R George Robin, A, Bavani Ladha (2012) Biofilm inhibitory effect of silver nanoparticles coated catheter against Staphylococcus aureus and evaluation of its synergistic effect with antibiotics. 3(2), 259-265.
George O'toole, Roberto Kolter (1998) Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. 28(3), 449-461.
P Vázquez-Aragón, P Cascales-Sánchez, M Lizan-García, D García-Olmo, M Villar-Cánovas, P González-Camuñas, A Martínez-Morenoa (2003) Estudio prospectivo de la frecuencia de infección nosocomial y factores de riesgo en un servicio de cirugía general. 74(2), 86-91.
Von Eiff, C Jansen, B Kohnen, W Becker, K (2005) management and prophylaxis. 65, 179-214.
Published
2013-06-24
Issue
Section
License
Copyright (c) 2013 Authors and Global Journals Private Limited

This work is licensed under a Creative Commons Attribution 4.0 International License.